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Summary E-cadherin (E-CD) is a calcium-dependent cell-cell adhesion molecule which is expressed in almost
all epithelial tissues. E-CD expression is involved in epidermal morphogenesis and is reduced during tumour
progression of mouse epidermal carcinogenesis. It has been suggested that E-CD could play a role as an
invasion-suppressor molecule. In the present work we have studied the E-CD expression in 31 patients with
basal cell carcinoma (BCC) using an immunohistochemical technique with a monoclonal antibody (HECD-1)
specific for human E-CD. E-CD expression was preserved in all specimens of superficial and nodular BCC,
and was reduced in 10 of 15 infiltrative BCCs. A heterogeneous distribution of cells with different immuno-
staining intensity was more frequently observed in specimens of infiltrative BCC. These results suggest that
E-CD might be related to the growth pattern and the local aggressive behaviour of BCC, and support the idea
that E-CD might play a role as an invasion-suppressor molecule in vivo.
Cadherins are calcium-dependent cell-cell adhesion trans-
membrane glycoproteins present on most cells. They mediate
homophilic (like-with-like) adhesion between cells (Takeichi,
1991). Cadherins play a crucial role during embryogenesis
and morphogenesis, as well as in the maintenance of adult
tissue architecture (Takeichi, 1991). This family of adhesion
molecules may be subdivided in two major groups, such as
classic cadherins (including the first three characterised
cadherins: epithelial type E-CD, neural type N-CD and
placental type P-CD) and desmosomal cadherins. Classic
cadherins are concentrated in the adherens type of intercel-
lular junctions (Magee & Buxton, 1991).
In normal mouse and human epidermis, at least two clas-
sical cadherins are expressed: E-CD and P-CD (Eidelman et
al., 1989; Hirai et al., 1989; Shimoyama et al., 1989; Burge &
Schomberg, 1992). By indirect immunofluorescence or by
immunohistochemical techniques E-CD is detected on the
lateral and upper surfaces of basal keratinocytes (polarised
form), and all around the periphery of keratinocytes in the
spinous layer (non-polarised form), with a punctate linear
pattern. It has been shown that E-CD plays an important
role in epidermal morphogenesis (Hirai et al., 1989; Nichol-
son et al., 1991; Wheelock & Jensen, 1992). On the other
hand, E-CD expression is reduced during tumour progression
of mouse epidermal carcinogenesis, suggesting that distur-
bances in E-CD-mediated cell-cell adhesion may be impli-
cated in this process (Navarro et al., 1991; Ruggeri et al.,
1992). Furthermore, a possible role for E-CD as an invasion-
suppressor molecule has been suggested (Behrens et al., 1989;
Frixen et al., 1991; Vleminckx et al., 1991; Chen & Obrink,
1991). Some cancer cell lines derived from poorly differenti-
ated human carcinomas had lost E-CD expression and were
invasive in collagen gels, whereas other highly differentiated
cell lines in which E-CD was expressed were not invasive
(Frixen et al., 1991). In biopsy specimens of human car-
cinomas, E-CD is frequently reduced or absent in the most
dedifferentiated tumours (Shimoyama & Hirohashi, 1991a,b;
Shiozaki et al., 1991; Schipper et al., 1991; Oka et al., 1992,
1993; Umbas et al., 1992; Van der Wurff et al., 1992; Inoue
et al., 1992; Matsuura et al., 1992; Dorudi et al., 1993;
Gamallo et al., 1993; Kinsella et al., 1993; Mayer et al., 1993;
Terpe et al., 1993). In addition, cell-cell adhesion and glan-
dular differentiation of the human colon carcinoma cell line
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SW1222, which displays high levels of E-CD, was inhibited
by a monoclonal antibody (HECD-1) specific for E-CD (Pig-
natelli et al., 1992). Thus, all these observations suggest that
E-CD plays some role in the genesis of histological
differentiation and could be implicated in the acquisition of
invasive potential of human cancer cells.
In this study, we report the distribution of E-CD in BCC
of skin. This tumour is the most common cancer in humans.
Although BCC has a low metastatic potential, some cases
show increased aggressiveness and tendency to recurrence
after treatment, most frequently in infiltrative, morpheaform
and metatypical (basosquamous) histological types (Miller,
1991). Herein, we have examined E-CD expression by
immunohistochemistry with the monoclonal antibody
HECD-1 (Shimoyama et al., 1989) in three different histo-
logical types of BCC (superficial, nodular and infiltrative),
which differ in both growth pattern and local invasiveness.
E-CD expression in tumours has been compared with the
distribution and intensity of E-CD immunostaining in nor-
mal human epidermis.
Materials and methods
Tissue specimens
Thirty-one primary untreated BCCs, each from a different
patient, were surgically removed and the diagnosis confirmed
by histopathology. Tumours of superficial (eight cases),
nodular (eight cases) and infiltrative (15 cases) histological
types were included. Clinical data are summarised in Table I.
Normal human skin was obtained from cosmetic surgery
procedures. Tumour tissue and normal human skin obtained
from fresh specimens were embedded in optimal cutting
temperature (OCT) compound (Miles Laboratory, Napervi-
lle, IL, USA), snap frozen in liquid nitrogen-cooled isopen-
tane and stored at - 70°C. The remaining tumour tissue was
routinely fixed in 10% formalin for 24 h and embedded in
paraffin.
Antibody
A mouse monoclonal antibody (HECD-1) specific for human
E-CD (Shimoyama et al., 1989) was used. This monoclonal
antibody was kindly provided by M. Takeichi (Kyoto
University, Kyoto, Japan).
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Table I Summary of E-cadherin expression in relation to clinical data and histological type for 31 patients with basal cell
carcinoma of the skin
Patient no. Sex/age (years)
1 F/39
2 M/37
3 M/75
4 F/70
5 M/45
6 M/73
7 F/66
8 M/60
9 M/70
10 F/61
11 F/68
12 M/56
13 F/56
14 F/69
15 M/78
16 M/80
17 F/74
18 M/52
19 M/78
20 M/60
21 M/80
22 M/70
23 F/59
24 M/89
25 M/62
26 F/78
27 M/70
28 M/60
29 F/58
30 M/59
31 M/91
Location
Abdomen
Back
Abdomen
Forehead
Back
Back
Back
Back
Eyelid
Nose
Upper lip
Upper lip
Neck
Hand
Ear
Forehead
Upper lip
Nose
Ear
Eyelid
Forehead
Nose
Nose
Chest wall
Forehead
Ear
Nose
Nose
Nose
Nose
Cheek
Size (mm)
15 x 15
15 x 12
12 x 7
20 x 15
40 x 30
25 x 25
30 x 30
13 x 14
15 x 10
8 x 6
10 x 10
12 x 10
10 x 5
20 x 20
16 x 7
10 x 10
10 x 10
20 x 20
15 x 6
20 x 15
12 x 10
10 x 10
10 x 10
30 x 40
6 x 6
20 x 9
30 x 45
15 x 10
20 x 8
15 x 8
20 x 20
Histological type
Superficial
Superficial
Superficial
Superficial
Superficial
Superficial
Superficial
Superficial
Nodular
Nodular
Nodular
Nodular
Nodular
Nodular
Nodular
Nodular
Infiltrative
Infiltrative
Infiltrative
Infiltrative
Infiltrative
Infiltrative
Infiltrative
Infiltrative
Infiltrative
Infiltrative
Infiltrative
Infiltrative
Infiltrative
Infiltrative
Infiltrative
E-CD expression
Preserved
Preserved
Preserved
Preserved
Preserved
Preserved
Preserved
Preserved
Preserved
Preserved
Preserved
Preserved
Preserved
Preserved
Preserved
Preserved
Preserved
Preserved
Preserved
Preserved
Preserved
Reduced
Reduced
Reduced
Reduced
Reduced
Reduced
Reduced
Reduced
Reduced
Reduced
E-CD distribution
Homogeneous
Homogeneous
Homogeneous
Homogeneous
Homogeneous
Homogeneous
Heterogeneous
Heterogeneous
Homogeneous
Homogeneous
Homogeneous
Homogeneous
Homogeneous
Heterogeneous
Heterogeneous
Heterogeneous
Homogeneous
Homogeneous
Heterogeneous
Heterogeneous
Heterogeneous
Homogeneous
Homogeneous
Heterogeneous
Heterogeneous
Heterogeneous
Heterogeneous
Heterogeneous
Heterogeneous
Heterogeneous
Heterogeneous
E-cadherin expression by immunohistochemical technique
Immunostaining was performed by the extravidin-biotin-
alkaline phosphatase method as previously reported
(Navarro et al., 1991; Gamallo et al., 1993). Briefly, cryostat
sections of 5-6gm thickness were cut, air dried and fixed in
acetone at 4°C. The slides were incubated with the MAb
HECD-1 for 1 h at 37°C in a humidified chamber. The
primary antibody was used at a dilution of 1:250, made in
150 mM sodium chloride, 10 mM HEPES pH 7.4, 10 mM cal-
cium chloride (HMF-Ca buffer), containing 1% (w/v) bovine
serum albumin (BSA). After washing in Tris buffer pH 7.4,
with 1% BSA, sections were incubated with biotinylated goat
anti-mouse IgG (Biomakor, Rehovot, Israel) diluted 1:200
for 30 min at 37°C, followed by a 30 min incubation with a
1:250 dilution of extravidin-alkaline phosphatase complex
(Biomakor) at 37°C. Dilution of the secondary antibody was
made in Tris buffer containing preimmune goat serum (1:50
dilution). Extravidin-alkaline phosphatase complex was
diluted in Tris buffer-1% BSA. The alkaline phosphatase
activity was developed using 2 mg of naphthol AS-MX phos-
phate (Sigma, St Louis, MO, USA) dissolved in 200 jil of
dimethylformamide (Sigma), and mixed with 0.1 M Tris
buffer pH 8.2, made up to 10 ml. To block endogenous
alkaline phosphatase, 10 Il of a levamisole solution 1 M
(Sigma) was added. The reaction was completed with 10 mg
of fast red dye (Sigma) as the chromogen group. The sections
were counterstained with Meyer haematoxylin and mounted
for light microscopic study. Negative controls consisted of
consecutive sections of each tumour in which the primary
antibody was replaced with an irrelevant monoclonal
antibody of the same species directed towards Aspergillus
niger glucose oxidase (mouse IgG1; Dako, Glostrup, Den-
mark).
Evaluation ofthe immunohistochemical staining
All specimens were read blind by two experienced
pathologists. The intensity of immunostaining in tumour cells
was classified as (+ +) when as strong as the normal epider-
mis, (+) when weak and (-) when cells were not stained.
'Preserved E-CD expression' implied that more than 75% of
the tumour cells were strongly (+ +) stained. 'Reduced exp-
ression' of E-CD implied that more than 25% of the tumour
cells were positively stained but less than 75% of the tumour
cells were strongly (+ +) stained. 'Severely reduced' E-CD
expression implied that more than 75% of cells were not
stained and 'absent E-CD expression' meant that E-CD
staining was completely lost. In case of disagreement by the
two pathologists, the slides were reviewed by a third
pathologist who did not know the nature of the antigen
being tested and the hypothesis under investigation. A con-
sensus based on the two nearest opinions was obtained.
Statistical analysis
The chi-square test was used to analyse the statistical
significance between E-CD expression and both histological
pattern and sex. The Mann-Whitney U-test was used to
evaluate the statistical significance between E-CD expression
and both age and tumour size.
Results
Results are summarised in Tables I and II. E-CD was ex-
pressed with variable intensity in all specimens without
exception and showed a punctate linear pattern around the
periphery of tumour cells. The E-CD immunostaining of the
outer cell layer of the tumour nests was occasionally positive
on the cell surface in contact with the basement membrane
zone (BMZ) (Figure lb, d and f). On the contrary, E-CD
was absent on the cell surface in contact with the BMZ in the
basal keratinocytes of normal epidermis (Figure 1h).
E-CD expression was preserved in all specimens of
superficial BCC (Figure la), and was widely homogeneous in
the tumour nests in six cases (Figure lb). Reduced staining of
the inner cell layers was seen in two cases.
Preserved expression of E-CD was also found in the eightE-CADHERIN IN BCC 159
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Figure 1 Histopathology (a, c, e and g) and immunostaining for E-cadherin (b, d, f and h) in different histological types of basal
cell carcinomas (BCCs) and normal epidermis. Superficial BCC (a) and nodular BCC (c), with, strong and homogeneous E-CD
immunostaining (b and d). Infiltrative BCC (e), with reduced and heterogeneous E-CD immunostaining (f). Normal epidermis (g),
with expression of E-CD in all the living layers (h). E-CD staining is stronger in the spinous layer than in the basal layer. Note that
E-CD immunostaining is absent on the cell surface in contact with basement membrane zone (BMZ) in normal epidermis (h,
arrows), whereas E-CD staining is positive on the cell surface in contact with BMZ in some tumour cells (b, d and f,
arrowheads).
nodular BCCs examined (Figure ic). In three cases, partic-
ularly in the largest tumour nests, cells at the periphery were
more strongly stained than those of the inner layer. E-CD
expression was homogeneous throughout the tumour mass in
the other five cases (Figure ld).
Finally, 15 infiltrative BCCs were studied (Figure le). Ten
tumours showed reduced expression of E-CD. A homo-
geneous weak staining was found in two tumours, and a
heterogeneous staining was found in eight tumours. Six of
them showed a mixed population of weak and strong cells,
and two tumours showed groups of negative cells interming-
led with positive cells (Figure 1f). E-CD expression was160 A. PIZARRO et al.
Table II Relationship between histological type of basal cell carcinoma and E-cadherin expression
Preserved Reduced Severely reducedl
Histological type Homogeneous Heterogeneous Homogeneous Heterogeneous absent
Superficial 6 2 0 0 0
Nodular 5 3 0 0 0
Infiltrative 2 3 2 8 0
Chi-square test P<0.05.
preserved in the other five cases of infiltrative BCC, being
homogeneous in two cases and heterogeneous in three.
Statistical analysis showed a significant association
between reduction in E-cadherin expression and the
infiltrative growth pattern (Table II). No significant correla-
tion was found between E-CD expression and age, sex or
tumour size.
Discussion
One of the most characteristic features of human BCC of
skin is the low metastatic potential of this neoplasm
(Domarus & Stevens, 1984; Lo et al., 1991). However, some
tumours have elevated local invasiveness (Siegle et al., 1986;
Leffel et al., 1991; Ko et al., 1992). Although metastatic
potential does not seem to be related to histological type of
BCC, the local aggressive behaviour and the tendency to
recurrence after therapy seem to be higher in morpheaform
and infiltrative subtypes (Miller, 1991).
In view of the fact that experimental studies suggest a role
for E-CD as an invasion-suppressor molecule (Behrens et al.,
1989; Frixen et al., 1991; Vleminckx et al., 1991; Chen &
Obrink, 1992), we considered of great interest the study of
E-CD expression in different histological types of human
BCC of skin. Our results showed preserved E-CD expression
in all cases of superficial BCC. This histological type of BCC
is characterised by tumour nests attached to the undersurface
of the epidermis, with little penetration into the dermis. The
peripheral cell layer of the nests often shows a well-
demarcated palisading (Lever & Schaumburg-Lever, 1990).
We also found preserved E-CD expression in nodular BCC,
which is characterised by masses of various shapes and sizes
embedded in the dermis. Tumour nests of nodular BCC have
a rounded smooth outline and well-developed palisading
(Lever & Schaumburg-Lever, 1990). In contrast to the former
histological types of BCC, E-CD expression was reduced in
most cases (10 of 15) of infiltrative BCC. The growth pattern
of infiltrative BCC is characterised by the presence of small
cell nests and aggregates with spiky irregular configuration
and poorly developed peripheral palisading, as well as cords
and strands of tumour cells extending from the basal layer of
the epidermis into the deep dermis (Siegle et al., 1986). These
results suggest that reduced E-CD expression may be related
to the infiltrative growth pattern. On the other hand, we have
not observed a significant association between E-CD expres-
sion and age, sex or tumour size. We have not performed
statistical analysis of the correlation between E-CD expres-
sion and anatomical site because of the diversity in the
location of the tumour included in this short series (Table I).
Further studies on a large scale are needed to clarify this
question.
With regard to the pattern of E-CD expression in these
tumours, we have observed a heterogeneous distribution in a
few cases of superficial and nodular BCC. In these cases,
E-CD expression was typically strong at the periphery of the
tumour nests and weak in the inner cell layers. In contrast
E-CD expression was heterogeneous in most cases of infil-
trative BCC, with intermingled populations of cells of
different immunostaining intensity. Thus, we can speculate
that a more homogeneous and stable E-CD expression
among cells in contact may favour the superficial and
nodular growth pattern, whereas a more heterogeneous and
unstable E-CD expression may favour the infiltrative growth
pattern. Many other observations also support the idea that
tumours of heterogeneous composition may have increased
invasive potential (Hashimoto et al., 1989; Mareel et al.,
1991; Bussemakers et al., 1992: Umbas et al., 1992). Thus,
our results strongly suggest that E-CD expression is related
to the growth pattern and the local invasiveness of BCC.
Furthermore, many other studies also support the idea that
E-CD is involved in the growth pattern of epithelial neo-
plasms in humans. For example, E-CD tends to be preserved
in gastric carcinomas and ductal breast carcinomas with an
expansive growth pattern, and impaired in those with an
infiltrative growth pattern (Oka et al., 1992, 1993). In the
same way, E-CD is absent in almost all cases of lobular
breast carcinoma, a tumour characterised by a diffuse
infiltrating pattern of small cells extending in single lines
between collagen bundles (Gamallo et al., 1993; Rasbridge et
al., 1993). All these studies support the view that E-CD may
be one of the multiple biological factors involved in the
growth pattern, local invasiveness and metastatic potential of
human carcinomas (Van Roy & Mareel, 1992; Aznavoorian
et al., 1993).
The apparently contradictory observation of preserved
E-CD expression in a few cases of infiltrative BCC may be
explained, at least in part, by the existence of some putative
mechanisms that interfere with cadherin function in cancer
cells, or that could overcome the invasive-suppressor function
of E-CD operating in the E-CD-positive carcinomas (Mat-
suyoshi et al., 1992; Shimoyama et al., 1992; Behrens et al.,
1993). However, despite their common aggressive growth
pattern, not all infiltrative BCCs have the same tumori-
genicity and local aggressive behaviour. Thus, further studies
are needed to investigate the possible role for E-CD in
reducing tumorigenicity and invasiveness in those infiltrative
BCCs with preserved E-CD expression, as well as the func-
tional status of E-CD in these tumours. On the other hand,
increased expression of other cell adhesion molecules in BCC,
such as the integrin receptors VLA-2 and VLA-3 (Stamp &
Pignatelli, 1991), may also contribute to the pattern of
growth and the clinical behaviour of BCC.
Finally, we have observed E-CD expression on the cell
surface in contact with the basement membrane zone in some
tumour cells, whereas E-CD is absent in this surface of basal
cells in normal human epidermis. This phenomenon was
observed in all studied histological types of BCC. We do not
know the biological significance, if any, of this observation.
However, the expression of E-CD on the cell surface in
contact with the extracellular matrix may be a consequence
of the loss of cell polarity that is usually found during
epithelial oncogenesis (Schoenenberger & Matlin, 1991).
In summary, the observations made in this study suggest
that E-CD expression may contribute to the growth pattern
and the local aggressive behaviour of BCC. These results
further support the idea that E-CD might play a role as an
invasion-suppressor molecule in vivo.
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